Back to ZNTL
MARSHALL WACE, LLP ZNTL Position History
Zentalis Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$1M
Q3 2026
Peak value
$12M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $12M |
| Q2 2023 | $2.5M |
| Q3 2023 | $4.2M |
| Q3 2023 | $1.2M |
| Q4 2023 | $1.3M |
| Q1 2024 | $1.4M |
| Q2 2024 | $364K |
| Q3 2024 | $328K |
| Q4 2024 | $270K |
| Q4 2025 | $101K |
| Q4 2025 | $233K |
| Q2 2026 | $585K |
| Q2 2026 | $2.3M |
| Q3 2026 | $156K |
| Q3 2026 | $1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1M | 370.5K | — | — |
| Q3 2026 | $156K | 56.4K | — | — |
| Q2 2026 | $2.3M | 470.9K | — | — |
| Q2 2026 | $585K | 120.6K | — | — |
| Q4 2025 | $233K | 172.7K | — | — |
| Q4 2025 | $101K | 75.1K | — | — |
| Q4 2024 | $270K | 89.0K | — | — |
| Q3 2024 | $328K | 89.0K | — | — |
| Q2 2024 | $364K | 89.0K | — | — |
| Q1 2024 | $1.4M | 89.0K | — | — |
| Q4 2023 | $1.3M | 89.0K | — | — |
| Q3 2023 | $1.2M | 59.1K | — | — |
| Q3 2023 | $4.2M | 211.8K | — | — |
| Q2 2023 | $2.5M | 89.7K | — | — |
| Q2 2023 | $12M | 426.4K | — | — |